These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. RISK FACTORS FOR RECURRENCES OF CENTRAL SEROUS CHORIORETINOPATHY. Matet A; Daruich A; Zola M; Behar-Cohen F Retina; 2018 Jul; 38(7):1403-1414. PubMed ID: 28570485 [TBL] [Abstract][Full Text] [Related]
3. Retinal Pigment Epithelial Features in Central Serous Chorioretinopathy Identified by Polarization-Sensitive Optical Coherence Tomography. Roberts P; Baumann B; Lammer J; Gerendas B; Kroisamer J; Bühl W; Pircher M; Hitzenberger CK; Schmidt-Erfurth U; Sacu S Invest Ophthalmol Vis Sci; 2016 Apr; 57(4):1595-603. PubMed ID: 27046123 [TBL] [Abstract][Full Text] [Related]
4. Choroidal thickness measurement by enhanced depth imaging and swept-source optical coherence tomography in central serous chorioretinopathy. Hamzah F; Shinojima A; Mori R; Yuzawa M BMC Ophthalmol; 2014 Nov; 14():145. PubMed ID: 25421855 [TBL] [Abstract][Full Text] [Related]
5. Pathogenesis of Central Serous Chorioretinopathy and the Link Between Choroidal Hyperpermeability and Retinal Pigment Epithelium Pump Reversal. Fossataro F; Fossataro C; Abraham N; Fouad Y; Mrejen S; Tan ACS; Voichanski S; Sarraf D Am J Ophthalmol; 2024 Oct; 266():206-217. PubMed ID: 38719133 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of reduced-fluence photodynamic therapy for central serous chorioretinopathy associated with combined serous retinal detachment and fovea-involving pigment epithelial detachment. Arf S; Hocaoglu M; Sayman Muslubas I; Karacorlu M Int Ophthalmol; 2017 Jun; 37(3):483-489. PubMed ID: 27392913 [TBL] [Abstract][Full Text] [Related]
7. Multimodal Imaging and Choroidal Volumetric Changes After Half-fluence PDT in Central Serous Chorioretinopathy. Munk MR; Shah R; Pappas F; Baddar D; Wong B; Jampol LM; Fawzi AA Curr Eye Res; 2016; 41(1):97-106. PubMed ID: 25612245 [TBL] [Abstract][Full Text] [Related]
8. Reduced-fluence photodynamic therapy for subfoveal serous pigment epithelial detachment with choroidal vascular hyperpermeability. Goto S; Gomi F; Ueno C; Nishida K Am J Ophthalmol; 2012 Nov; 154(5):865-871.e1. PubMed ID: 22840480 [TBL] [Abstract][Full Text] [Related]
9. OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY OF FLAT IRREGULAR PIGMENT EPITHELIUM DETACHMENT IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY. Bousquet E; Bonnin S; Mrejen S; Krivosic V; Tadayoni R; Gaudric A Retina; 2018 Mar; 38(3):629-638. PubMed ID: 28267114 [TBL] [Abstract][Full Text] [Related]
10. Dark and white lesions observed in central serous chorioretinopathy on optical coherence tomography angiography. De Bats F; Cornut PL; Wolff B; Kodjikian L; Mauget-Faÿsse M Eur J Ophthalmol; 2018 Jul; 28(4):446-453. PubMed ID: 29554817 [TBL] [Abstract][Full Text] [Related]
11. One-year choroidal thickness results after photodynamic therapy for central serous chorioretinopathy. Maruko I; Iida T; Sugano Y; Furuta M; Sekiryu T Retina; 2011 Oct; 31(9):1921-7. PubMed ID: 21878850 [TBL] [Abstract][Full Text] [Related]
12. [Analysis of fundus fluorescein angiography, indocyanine green angiography and choroidal thickness in central serous chorioretinopathy]. Li L; Li DH; Yang ZK; Bian AL; Chen YX; Dong FT Zhonghua Yan Ke Za Zhi; 2012 Oct; 48(10):878-82. PubMed ID: 23302240 [TBL] [Abstract][Full Text] [Related]
13. FUNDUS AUTOFLUORESCENCE LIFETIMES AND CENTRAL SEROUS CHORIORETINOPATHY. Dysli C; Berger L; Wolf S; Zinkernagel MS Retina; 2017 Nov; 37(11):2151-2161. PubMed ID: 28099314 [TBL] [Abstract][Full Text] [Related]
14. Assessment of macular choroidal thickness by optical coherence tomography and angiographic changes in central serous chorioretinopathy. Jirarattanasopa P; Ooto S; Tsujikawa A; Yamashiro K; Hangai M; Hirata M; Matsumoto A; Yoshimura N Ophthalmology; 2012 Aug; 119(8):1666-78. PubMed ID: 22521082 [TBL] [Abstract][Full Text] [Related]
15. Chronic central serous chorioretinopathy imaged by optical coherence tomographic angiography. Quaranta-El Maftouhi M; El Maftouhi A; Eandi CM Am J Ophthalmol; 2015 Sep; 160(3):581-587.e1. PubMed ID: 26133250 [TBL] [Abstract][Full Text] [Related]
16. Retinoschisis in eyes with pachychoroid and retinal pigment epithelial atrophy. Baek J; Lee JH; Lee WK Graefes Arch Clin Exp Ophthalmol; 2019 Sep; 257(9):1863-1871. PubMed ID: 31222406 [TBL] [Abstract][Full Text] [Related]
17. Retro-mode Imaging for retinal pigment epithelium alterations in central serous chorioretinopathy. Shin YU; Lee BR Am J Ophthalmol; 2012 Jul; 154(1):155-163.e4. PubMed ID: 22503695 [TBL] [Abstract][Full Text] [Related]
18. OCT biomarkers related to subthreshold micropulse laser treatment effect in central serous chorioretinopathy. Zheng F; He J; Su Z; Liu Y; Xu Y; Liu L; Ye P BMC Ophthalmol; 2022 Jun; 22(1):252. PubMed ID: 35668416 [TBL] [Abstract][Full Text] [Related]
19. Optical coherence tomographic enhanced depth imaging of polypoidal choroidal vasculopathy. Yang LH; Jonas JB; Wei WB Retina; 2013 Sep; 33(8):1584-9. PubMed ID: 23584691 [TBL] [Abstract][Full Text] [Related]
20. Comparison of the optical coherence tomographic characters between acute Vogt-Koyanagi-Harada disease and acute central serous chorioretinopathy. Lin D; Chen W; Zhang G; Huang H; Zhou Z; Cen L; Chen H BMC Ophthalmol; 2014 Jun; 14():87. PubMed ID: 24974016 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]